GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumibird (XPAR:LBIRD) » Definitions » Debt-to-Revenue

Lumibird (XPAR:LBIRD) Debt-to-Revenue : 0.59 (As of Jun. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Lumibird Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Lumibird's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €13.26 Mil. Lumibird's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €103.73 Mil. Lumibird's annualized Revenue for the quarter that ended in Jun. 2023 was €196.93 Mil. Lumibird's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 0.59.


Lumibird Debt-to-Revenue Historical Data

The historical data trend for Lumibird's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumibird Debt-to-Revenue Chart

Lumibird Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.68 0.67 0.59 N/A

Lumibird Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.68 0.53 0.59 N/A

Competitive Comparison of Lumibird's Debt-to-Revenue

For the Diagnostics & Research subindustry, Lumibird's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumibird's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumibird's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lumibird's Debt-to-Revenue falls into.



Lumibird Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Lumibird's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(65.562 + 48.618) / 194.294
=0.59

Lumibird's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(13.258 + 103.726) / 196.928
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.


Lumibird Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lumibird's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumibird (XPAR:LBIRD) Business Description

Traded in Other Exchanges
Address
2 rue du Paul Sabatier, Lannion, FRA, 22300
Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.

Lumibird (XPAR:LBIRD) Headlines

No Headlines